NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/27/2025
Back to search
Official data from USPTO
KINIKSA ONE CONNECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000090567557Class
35, 36, 41, 44
Filing
90567557
Registration
7811656
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/27/2025
Trademark type
Combined
Nice classes
35, 36, 41, 44
Filing date
03/09/2021
Registration date
05/27/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2025
Last transaction
05/27/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-04-00
First use in commerce
2021-04-00
Drawing code
5
Owner type
83
Owner location
LONDON, GB
Examiner
FRIEDMAN, LESLEE ANN
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "KINIKSA" above and left justified with the words "ONECONNECT" with the "E" in "ONE" linked to the "C" in "CONNECT"; the color gray represents shading and contrast only and is not a feature of the mark.
Holders and representatives
Holders
KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.
Kiniksa Pharmaceuticals, Ltd.
Representatives
Maury M. Tepper, III TEPPER & EYSTER, PLLC
Technical classification
Nice Classes
Class 35Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting awareness of patient support offerings for autoimmune and autoinflammatory diseases and disorders; business administration of reimbursement and healthcare benefit information for autoimmune and autoinflammatory diseases and disorders and their treatment
Class 36
insurance servicesbenefits verification in the nature of insurance claims administration; providing online financial assistance with insurance benefits and coverage for health care providers and patients in the fields of autoimmune and autoinflammatory diseases and disorders
Class 41
Educational servicesconducting educational programs in the nature of webinars in the fields of autoimmune and autoinflammatory diseases and disorders and treatment and patient support options for these conditions
Class 44
Providing medical information for health care providers and patients in the fields of autoimmune and autoinflammatory diseases and disorders; medical support servicesproviding healthcare information to patients and healthcare professionals in the fields of autoimmune and autoinflammatory diseases and disorders
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/07/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2025
ALIE
ASSIGNED TO LIE
04/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/15/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/28/2025
GNRT
NON-FINAL ACTION E-MAILED
03/28/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/28/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/28/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/27/2025
IUAF
USE AMENDMENT FILED
12/17/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/17/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2024
EX5G
SOU EXTENSION 5 GRANTED
07/03/2024
EXT5
SOU EXTENSION 5 FILED
07/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/30/2023
EX4G
SOU EXTENSION 4 GRANTED
12/28/2023
EXT4
SOU EXTENSION 4 FILED
12/28/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/01/2023
EX3G
SOU EXTENSION 3 GRANTED
06/29/2023
EXT3
SOU EXTENSION 3 FILED
06/29/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/29/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/04/2023
EX2G
SOU EXTENSION 2 GRANTED
01/02/2023
EXT2
SOU EXTENSION 2 FILED
01/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/05/2022
EX1G
SOU EXTENSION 1 GRANTED
07/01/2022
EXT1
SOU EXTENSION 1 FILED
07/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/04/2021
DOCK
ASSIGNED TO EXAMINER
10/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/08/2021
NWAP
NEW APPLICATION ENTERED
03/12/2021
Continuous trademark protection
Get notified about every new filing that threatens KINIKSA ONE CONNECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.